PATHOLOGY SERVICES PC
NPI: 1992777601
· CEDAR CITY, UT 84721
· Dermatology Physician
· NPI assigned 02/06/2006
$267K
Total Medicaid Paid
Provider Details
| Authorized Official | OSMOND, GREGORY (PRESIDENT) |
| NPI Enumeration Date | 02/06/2006 |
Related Entities
Other providers sharing the same authorized official: OSMOND, GREGORY
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
44 |
$343.51 |
| 2019 |
476 |
$6K |
| 2020 |
506 |
$12K |
| 2021 |
1,892 |
$66K |
| 2022 |
2,431 |
$84K |
| 2023 |
1,897 |
$65K |
| 2024 |
714 |
$34K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,802 |
5,859 |
$241K |
| 88307 |
|
230 |
224 |
$13K |
| 88342 |
|
385 |
347 |
$7K |
| 88141 |
|
130 |
126 |
$2K |
| 88312 |
|
25 |
24 |
$1K |
| 88304 |
|
109 |
101 |
$1K |
| 88341 |
|
49 |
39 |
$838.23 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
29 |
12 |
$825.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
29 |
12 |
$275.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
29 |
12 |
$258.06 |
| 0753T |
|
143 |
117 |
$0.00 |